No. |
Year |
Title |
Author |
Corresponding |
Journal |
Vol. |
Pages |
1 |
2020 |
Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. |
Okuyama T, Shirakawa J, Tajima K, Ino Y, Vethe H, Togashi Y, Kyohara M, Inoue R, Miyashita D, Li J, Goto N, Ichikawa T, Yamasaki S, Ohnuma H, Takayanagi R, Kimura Y, Hirano H, Terauchi Y. |
Shirakawa J |
Int J Mol Sci. |
21 |
7815 |
2 |
2020 |
Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. |
Kyohara M, Shirakawa J, Okuyama T, Togashi Y, Inoue R, Li J, Miyashita D, Terauchi Y. |
Shirakawa J |
Diabetol Metab Syndr |
12 |
83 |
3 |
2020 |
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
Charoensuka C, Jungtrakoon P, Chanprasert C, Tangjittipokin W, Shirakawa J, Togashi Y, Orime K, Songprakhon C, Chaichanad C, Abubakar Z, Ouying P, Sujjitjoon J, Doria A, Plengvidhya N, Yenchitsomanus P |
Yenchitsomanus P |
Mol Cell Endocrinol. |
522 |
111126 |
4 |
2021 |
The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes |
Inoue R, Nishiyama K, Li J, Miyashita D, Ono M, Terauchi Y, Shirakawa J. |
Shirakawa J |
Cells |
10(7) |
1589 |
5 |
2021 |
The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling |
Okuyama T, Kyohara M, Terauchi Y, Shirakawa J. |
Shirakawa J |
Int J Mol Sci |
22(13) |
6817 |
6 |
2021 |
Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report |
Hasebe M, Shirakawa J, Miyashita D, Kunishita R, Kyohara M, Okuyama T, Togashi Y, Terauchi Y. |
Shirakawa J |
J Med Case Rep |
15(1) |
390 |
7 |
2021 |
Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes |
Shirakawa J |
Shirakawa J |
Diabetol Int. |
12(4) |
349-355 |
8 |
2021 |
Validity and reliability of the Japanese version of the diabetes knowledge test among in-patients with type 2 diabetes |
Minami T, Shirakawa J, Hiiragi H, Yamada T, Suzuki Y, Shirabe S, Maeda H, Terauchi Y |
Terauchi Y |
J Diabetes Investig |
13(3) |
580-587 |
9 |
2021 |
Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study |
Terui S, Akamatsu R, Arai M, Inoue R, Okuyama T, Kyohara M, Li J, Tsuno T, Miyashita D, Togashi Y, Terauchi Y, Shirakawa J. |
Shirakawa J |
Diabetes Ther. |
12(11) |
2873-2889 |
10 |
2021 |
Pancreatic β-cell fate in subjects with COVID-19 |
Shirakawa J |
Shirakawa J |
J Diabetes Investig |
12(12) |
2126-2128 |
11 |
2022 |
Insulin regulates arginine-stimulated insulin secretion in humans |
Halperin F, Mezza T, Li P, Shirakawa J, Kulkarni RN, Goldfine AB. |
Goldfine AB |
Metabolism |
128 |
155117 |
12 |
2022 |
Imeglimin Ameliorates β-Cell Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway |
Li J, Inoue R, Togashi Y, Okuyama T, Satoh A, Kyohara M, Nishiyama K, Tsuno T, Miyashita D, Kin T, Shapiro AMJ, Chew RSE, Teo AKK, Oyadomari S, Terauchi Y, Shirakawa J. |
Shirakawa J |
Diabetes |
71(3) |
424-439 |
13 |
2022 |
Recent developments in Phos-tag electrophoresis for the analysis of phosphoproteins in proteomics |
Hirano H, Shirakawa J |
Shirakawa J |
Expert Rev Proteomics. |
22 |
12 |